A Randomized, Crossover Study to Assess the Effects of Dietary Fiber-containing Bars on Glucose and Insulin Responses

Completed · Not applicable

Conditions studied: Blood Glucose, Insulin Sensitivity, Dietary Fiber

In brief

This randomized, crossover study will include four clinic visits: one screening (day -7) and three test visits (days 0, 2, 4). The objective of this study is to assess the effects of dietary fiber-containing bars, at two doses of fiber, compared to a control product, on postprandial glucose and insulin responses in healthy adult men and women.

Key facts

Study ID

NCT03796286

Run by

Midwest Center for Metabolic and Cardiovascular Research

People needed

41

Starts

2018-12-14

Expected to finish

2019-02-27

Last updated by the study team

2019-07-24

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Male or female, 18-65 y of age, inclusive.
• Subject has a body mass index of 18.5 to 32.0 kg/m, inclusive.
• Subject is judged by the Investigator to be in generally good health on the basis of medical history and screening measurements.
• Subject is willing to consume the study products as described in the protocol.
• Subject is willing to maintain usual diet and activity patterns throughout the study.
• Subject has no plans to change smoking or other nicotine use during the study period.
• Subject is willing and able to attend all clinic visits.
• Subject has a vein access scale score of 7-10.
• Subject understands the study procedures and signs forms documenting informed consent to participate in the study and authorization for release of relevant protected health information to the study Investigator and is willing to complete study procedures.

You may not qualify if…

• Individual has a clinically significant gastrointestinal, endocrine (including Type 1 and Type 2 diabetes mellitus), cardiovascular, renal, hepatic, pulmonary, pancreatic, neurologic, or biliary disorder.
• Subject has pre-diabetes (fasting capillary glucose between 100 and 125 mg/dL) at screening. One re-test on a separate day will be allowed for subjects with no known history of pre-diabetes or diabetes who have a capillary glucose of 100 - 110 mg/dL at screening (visit 1).
• Individual has uncontrolled hypertension (systolic blood pressure ≥160 mm Hg or diastolic blood pressure ≥100 mm Hg) at screening.
• Individual has a history of cancer in the prior 2 years, except for non-melanoma skin cancer.
• Individual has extreme dietary habits (e.g., Atkins, vegan).
• Individual has had weight change of ±4.5 kg (10 lbs) in the previous 3 months.
• Individual has a known allergy, sensitivity, or intolerance to any ingredients in the study products.
• Individual is a female, who is pregnant, planning to be pregnant during the study period, lactating, or is of childbearing potential and is unwilling to commit to the use of a medically approved form of contraception throughout the study period.
• Individual has been exposed to any non-registered drug product within 30 days of screening.
• Individual has a condition the Investigator believes would interfere with his or her ability to provide informed consent or comply with the study protocol, or which might confound the interpretation of the study results or put the person at undue risk.

Where it is running

• MB Clinical Research — Boca Raton, Florida, United States
• Great Lakes Clinical Trials — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.